John Noseworthy - UnitedHealth Group Independent Director
| UNH Stock | EUR 466.65 7.10 1.54% |
Director
Dr. John H. Noseworthy, M.D. is Independent Director of the Company. Dr. Noseworthy served as president and CEO of Mayo Clinic from 2009 until his retirement in 2018, leading one of the largest and most prestigious academic health systems in the United States, with 12 billion in annual revenues and 68, 000 employees. With a focus on caring for patients with serious, complex illnesses, Mayo Clinic operates in five states and cares for more than 1 million people a year, from all 50 states and nearly 140 countries. Mayo Clinic is ranked No. 1 in the nation by U.S. News World Report . Prior to his appointment as CEO, Dr. Noseworthy served as chair of Mayo Clinic Department of Neurology, medical director of the Department of Development and vice chair of the Mayo Clinic Rochester Executive Board. Dr. Noseworthy received his M.D. degree from Dalhousie University in Halifax, Nova Scotia, Canada. He completed his neurology training at Dalhousie University and the University of Western Ontario, and a research fellowship at Harvard Medical School. He joined Mayo Clinic in 1990. He is the author of more than 150 research papers, chapters, editorials and several books, including the threevolumeNeurological Therapeutics Principles and Practice, now in its second edition. He also served as editorinchief of Neurology, the official journal of the American Academy of Neurology. since 2019.
| Age | 68 |
| Tenure | 5 years |
| Phone | 952 936 1300 |
| Web | https://www.unitedhealthgroup.com |
UnitedHealth Group Management Efficiency
The company has return on total asset (ROA) of 0.0776 % which means that it generated a profit of $0.0776 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2535 %, meaning that it generated $0.2535 on every $100 dollars invested by stockholders. UnitedHealth Group's management efficiency ratios could be used to measure how well UnitedHealth Group manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Carmen Martin | ATRESMEDIA | N/A | |
| Mathew Hart | Hollywood Bowl Group | 45 | |
| Melanie Dickinson | Hollywood Bowl Group | 40 | |
| Arturo Garijo | ATRESMEDIA | N/A | |
| Claire Tiney | Hollywood Bowl Group | 54 | |
| Nick Backhouse | Hollywood Bowl Group | N/A | |
| Aurora Sala | ATRESMEDIA | N/A | |
| Maria Franco | ATRESMEDIA | N/A | |
| Mikel Otriz | ATRESMEDIA | N/A | |
| Carlos Sanchiz | ATRESMEDIA | N/A | |
| Elmar Heggen | ATRESMEDIA | 50 | |
| Laurence Keen | Hollywood Bowl Group | 47 | |
| Ramon Villar | ATRESMEDIA | N/A | |
| Jose Martinez | ATRESMEDIA | N/A | |
| Mauricio Aldama | ATRESMEDIA | 69 | |
| Marco Drago | ATRESMEDIA | 72 | |
| Jose Garcia | ATRESMEDIA | N/A | |
| Monica Salat | ATRESMEDIA | N/A | |
| Jose Margenat | ATRESMEDIA | 61 | |
| Josep Ferran | ATRESMEDIA | N/A | |
| Nicolas Tavernost | ATRESMEDIA | 67 | |
Management Performance
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0776 |
UnitedHealth Group Leadership Team
Elected by the shareholders, the UnitedHealth Group's board of directors comprises two types of representatives: UnitedHealth Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of UnitedHealth. The board's role is to monitor UnitedHealth Group's management team and ensure that shareholders' interests are well served. UnitedHealth Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, UnitedHealth Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gail Wilensky, Independent Director | ||
| Richard Burke, Independent Chairman of the Board | ||
| Valerie Rice, Independent Director | ||
| Andrew Witty, President, Chief Executive Officer of Optum | ||
| Sir Witty, CEO Director | ||
| Stephen Hemsley, Non-Executive Chairman of the Board | ||
| John Rex, Chief Financial Officer, Executive Vice President | ||
| Dirk McMahon, Chief Executive Officer - UnitedHealthcare | ||
| DEllen Wilson, Executive Vice President - Human Capital | ||
| Steven Nelson, Executive Vice President CEO of UnitedHealthcare | ||
| Zachary Sopcak, VP Relations | ||
| William McNabb, Independent Director | ||
| John Noseworthy, Independent Director | ||
| Larry Renfro, Executive Vice President CEO - Optum | ||
| Robert Darretta, Independent Director | ||
| Jennifer Smoter, VP Officer | ||
| William Ballard, Independent Director | ||
| Glenn Renwick, Independent Director | ||
| Rupert Bondy, Ex Officer | ||
| Sandeep Dadlani, Ex Officer | ||
| Michele Hooper, Independent Director | ||
| Timothy Flynn, Independent Director | ||
| Thomas Roos, Senior Vice President, Chief Accounting Officer | ||
| Rodger Lawson, Independent Director | ||
| Frances Jacobs, IR Contact Officer | ||
| Matthew Friedrich, Executive Vice President Chief Legal Officer | ||
| Kenneth Shine, Independent Director | ||
| Edson Bueno, Director | ||
| D Wilson, Executive Vice President - Human Capital | ||
| F McNabb, Independent Director | ||
| Marianne Short, Executive Vice President Chief Legal Officer | ||
| David Wichmann, CFO, Executive Vice President and Presidentident - UnitedHealth Group Operations | ||
| Brian Thompson, Ex UnitedHealthcare | ||
| James Barry, Director Pennsylvania |
UnitedHealth Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is UnitedHealth Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0776 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 483.07 B | |||
| Shares Outstanding | 932.85 M | |||
| Shares Owned By Insiders | 0.46 % | |||
| Shares Owned By Institutions | 90.06 % | |||
| Price To Earning | 27.02 X | |||
| Price To Book | 6.65 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards UnitedHealth Group in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, UnitedHealth Group's short interest history, or implied volatility extrapolated from UnitedHealth Group options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for UnitedHealth Stock analysis
When running UnitedHealth Group's price analysis, check to measure UnitedHealth Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UnitedHealth Group is operating at the current time. Most of UnitedHealth Group's value examination focuses on studying past and present price action to predict the probability of UnitedHealth Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UnitedHealth Group's price. Additionally, you may evaluate how the addition of UnitedHealth Group to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |